COSENTYX® (secukinumab) prescribing information (external link)
This page includes promotional meetings and events organised and funded by Novartis Pharmaceuticals UK Ltd. Novartis products may be mentioned on this page and/or subsequent event pages.
Rheumatology
COSENTYX® (secukinumab)
Jun
04
Event
Psoriatic Disease in the Spotlight
Event
London City Hall
Novartis Immunology UK
18:45 Hrs - 21:15 Hrs
This promotional event has been organised and funded by Novartis Pharmaceuticals UK Ltd.
UK | April 2026 | FA-11615523
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
